{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:15:30Z","timestamp":1788981330259,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.biopha.2020.110252","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T20:02:57Z","timestamp":1590004977000},"page":"110252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Ergosterol ameliorates renal inflammatory responses in mice model of diabetic nephropathy"],"prefix":"10.1016","volume":"128","author":[{"given":"Chunyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.biopha.2020.110252_bib0005","first-page":"S79","article-title":"Nephropathy in diabetes","volume":"27","author":"Molitch","year":"2004","journal-title":"Diabet. Care"},{"key":"10.1016\/j.biopha.2020.110252_bib0010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: diagnosis, prevention, and treatment","volume":"28","author":"Gross","year":"2005","journal-title":"Diabet. Care"},{"key":"10.1016\/j.biopha.2020.110252_bib0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MED.0000000000000074","article-title":"Early diabetic nephropathy in type 1 diabetes: new insights","volume":"21","author":"Bjornstad","year":"2014","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.biopha.2020.110252_bib0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1900\/RDS.2015.12.110","article-title":"Diabetic nephropathy: new risk factors and improvements in diagnosis","volume":"12","author":"Tziomalos","year":"2015","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/j.biopha.2020.110252_bib0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(05)17789-7","article-title":"Chronic kidney disease: the global challenge","volume":"365","author":"El","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2020.110252_bib0030","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2020.110252_bib0035","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/01.ASN.0000070152.11927.4A","article-title":"Prevalence of kidney damage in Australian adults: the AusDiab kidney study","volume":"14","author":"Chadban","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2020.110252_bib0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/CS20120198","article-title":"Makino H: inflammation and the pathogenesis of diabetic nephropathy","volume":"124","author":"Wada","year":"2013","journal-title":"Clin. Sci."},{"key":"10.1016\/j.biopha.2020.110252_bib0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneph.2011.51","article-title":"Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy","volume":"7","author":"Navarro-Gonzalez","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2020.110252_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/157339908783502361","article-title":"Role of inflammation in diabetic nephropathy","volume":"4","author":"Fornoni","year":"2008","journal-title":"Curr. Diabet. Rev."},{"key":"10.1016\/j.biopha.2020.110252_bib0055","doi-asserted-by":"crossref","first-page":"146154","DOI":"10.1155\/2012\/146154","article-title":"Inflammation in diabetic nephropathy","volume":"2012","author":"Lim","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.biopha.2020.110252_bib0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4239\/wjd.v5.i3.393","article-title":"Rubio-Guerra AF: diabetic nephropathy and inflammation","volume":"5","author":"Duran-Salgado","year":"2014","journal-title":"World J. Diabet."},{"key":"10.1016\/j.biopha.2020.110252_bib0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cytogfr.2017.03.003","article-title":"IL-6 signaling in diabetic nephropathy: from pathophysiology to therapeutic perspectives","volume":"37","author":"Feigerlova","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biopha.2020.110252_bib0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cytogfr.2006.09.011","article-title":"The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications","volume":"17","author":"Navarro","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biopha.2020.110252_bib0075","doi-asserted-by":"crossref","first-page":"F697","DOI":"10.1152\/ajprenal.00016.2008","article-title":"MCP-1\/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy","volume":"294","author":"Tesch","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.biopha.2020.110252_bib0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00011-006-0070-4","article-title":"Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats","volume":"55","author":"Wu","year":"2006","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.biopha.2020.110252_bib0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bjp.0706972","article-title":"Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cells","volume":"150","author":"Kobori","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110252_bib0090","article-title":"Ergosterol alleviates kidney injury in streptozotocin-induced diabetic mice","volume":"2015","author":"Ang","year":"2015","journal-title":"Evid. Complement. Alternat. Med."},{"key":"10.1016\/j.biopha.2020.110252_bib0095","first-page":"705","article-title":"End-stage renal disease: symptom management and advance care planning","volume":"85","author":"O\u2019Connor","year":"2012","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.biopha.2020.110252_bib0100","doi-asserted-by":"crossref","first-page":"11957","DOI":"10.1021\/acs.jafc.8b04819","article-title":"Tea polypeptide ameliorates diabetic nephropathy through RAGE and NF-kappaB signaling pathway in Type 2 diabetes mice","volume":"66","author":"Deng","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2020.110252_bib0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11154-017-9422-3","article-title":"Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy","volume":"18","author":"Ilyas","year":"2017","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.biopha.2020.110252_bib0110","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2020.110252_bib0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/S0074-02762009000900041","article-title":"Ergosterol biosynthesis and drug development for Chagas disease","volume":"104","author":"Urbina","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.biopha.2020.110252_bib0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/biof.5520100211","article-title":"The role of oxidative stress and NF-kappaB activation in late diabetic complications","volume":"10","author":"Mohamed","year":"1999","journal-title":"Biofactors"},{"key":"10.1016\/j.biopha.2020.110252_bib0125","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s001250100000","article-title":"Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy","volume":"44","author":"Cooper","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2020.110252_bib0130","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.2337\/db06-0477","article-title":"Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy","volume":"55","author":"Schmid","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2020.110252_bib0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1620\/tjem.206.163","article-title":"Nuclear factor-kappaB activation in diabetic rat kidney: evidence for involvement of P-selectin in diabetic nephropathy","volume":"206","author":"Iwamoto","year":"2005","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.biopha.2020.110252_bib0140","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2362.2004.01429.x","article-title":"New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology","volume":"34","author":"Wolf","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.biopha.2020.110252_bib0145","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1039\/C6FO00117C","article-title":"The anti-hepatic fibrosis activity of ergosterol depended on upregulation of PPARgamma in HSC-T6 cells","volume":"7","author":"Tai","year":"2016","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2020.110252_bib0150","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.2174\/092986710793348581","article-title":"Oxidative stress in diabetic nephropathy","volume":"17","author":"Kashihara","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2020.110252_bib0155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s001250051142","article-title":"Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB","volume":"42","author":"Hofmann","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2020.110252_bib0160","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1097\/01.ASN.0000135055.61833.A8","article-title":"Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy","volume":"15","author":"Lee","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2020.110252_bib0165","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1463-1326.2005.00524.x","article-title":"Glucose control with insulin results in reduction of NF-kappaB-binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes","volume":"8","author":"Schiekofer","year":"2006","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.biopha.2020.110252_bib0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2337\/diabetes.54.1.125","article-title":"Nuclear factor-{kappa}B activity in {beta}-cells is required for glucose-stimulated insulin secretion","volume":"54","author":"Norlin","year":"2005","journal-title":"Diabetes"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220304443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220304443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:34:20Z","timestamp":1777689260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220304443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":34,"alternative-id":["S0753332220304443"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110252","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ergosterol ameliorates renal inflammatory responses in mice model of diabetic nephropathy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110252"}}